Sponsored By


Many teens
with food allergies
making risky choices.


Infant antiobiotics use
tied to childhood asthma

 
  
March 15, 2006
  
Welcome to ACAAI eNews — a bi-weekly aggregated news service from the American College of Allergy, Asthma & Immunology. To be removed from this distribution list, please see instructions at bottom.
 
Top Stories
 
Distance Learning
   
Drugs and Devices
      
Association News
   
Fellows-in-Training
   
Calendar
   
Archive
FIT Archive
 Members: update 
 e-mail address here
  
 Non-members:
 subscribe here

 

 ACAAI Home
 

Have you had a chance to read the OIG report in its entirety?

Do you believe that all of the recommendations made in the Joint Taskforce on Immunotherapy and Allergy Diagnostic Testing are applicable to your practice?

As a result of the OIG report, what do you plan to do?

Distance Learning
2005 ACAAI ANNUAL MEETING
• Symposia Online
Nov. 4-9, Anaheim
Link

2005 Board/Recertification Review Course:
DVDs, Audio CDs, MP3s
Link

ACAAI Tape Store
Complete Listing
Link

2004 ACAAI ANNUAL MEETING
• Symposia Online
Nov. 12-17, Boston
Link

2003 ACAAI ANNUAL MEETING
Nov. 7-12, 2003, New Orleans
• Two Symposia Online
Link

• Plenary Sessions CD-ROM and DVD
Link

Patient-Centered Allergy Practice
Endorsed by ACAAI, Sponsored by Physicians Practice
Link

 
Calendar

APRIL
AAAAI/ACAAI Certification/Maintenance of Certification Board Review Course
April 6-9
Westin Michigan Avenue Hotel
Chicago, Ill.
Link

Allergy and Clinical Immunology (64th Annual)
University of Minnesota
April 7, Minneapolis
Tel: 612-626-7600 or 800-776-8636
E-mail
Link


JULY
24th Annual Aspen Allergy Conference
July 26-29, Aspen, Colo.
Contact: Kathleen Goldy
Tel: 303-282-0491
E-mail
Link


ONGOING
World Allergy Organization Society Meetings

 

 Sponsored By

 
  
Top Stories
 
Study: Delta FVC a better test of adolescent asthma remission
The percentage drop in forced vital capacity (delta FVC) at the provocative concentration of methacholine causing a 20% fall in FEV1 (PC20) can differentiate between symptomatic asthma and clinical remission during adolescence, according to a study in Chest. Scientists at Seoul National University Hospital in Korea studied whether delta FVC was higher in adolescents with symptomatic asthma (n=40) than in those with clinical remission (n=80). The mean delta FVC of 15.5 percent in the symptomatic group was significantly higher than the 12.8 percent in the remission group with bronchial hyperresponsiveness or in the 11.5 percent in the remission group without bronchial hyperresponsiveness. Delta FVC appeared to be a better marker for discriminating between symptomatic asthma and remission than the PC20. 

Many allergic teens gambling with food
As many as 42 percent of teenagers with food allergies admit to risky eating habits, such as knowingly eating foods labeled "may contain" allergens, according to a survey presented at the 2006 AAAAI Annual Meeting in Miami Beach. Researchers at Mount Sinai School of Medicine in New York, polled 174 teenagers, whose average age was 16 years old. They also reported that many teens do not always carry self-injectable epinephrine. Only 43 percent reported carrying it to sports events, and less than 65 percent carry it “with friends, at school or dance events, or on dates.” They were most likely to carry self-injectable epinephrine when traveling (94 percent) or going out to eat (81 percent).

BMI may affect asthma drug response
A higher body mass index (BMI) in asthmatics appears to be linked to a decreased response to inhaled corticosteroids, according to a study in the European Respiratory Journal. However, subjects’ response to leukotriene antagonists was unaffected by BMI. Scientists at the University of Michigan Health System, Ann Arbor, looked at data from four double-blind trials in which more than 3,000 patients with moderate asthma were randomized to montelukast sodium, beclomethasone or placebo. Measures included days of asthma control, lung function (FEV1) and use of a rescue inhaler. The study was funded by Merck, manufacturer of Singulair.  

Nickel, gold among top 10 contact dermatitis allergens
Nickel and gold are among the leading causes of contact dermatitis, according to a study presented at the American Academy of Dermatology annual meeting, in San Francisco. Researchers at the Mayo Clinic analyzed results from contact dermatitis testing conducted on 3,854 patients. Each subject was tested with an average of 69 allergens, and 69 percent had at least one positive reaction and half had two or more positive reactions.
The study also confirmed that patch testing is effective for identifying contact allergens.   

Infant antibiotics use tied to childhood asthma
Babies treated with antibiotics before 12 months old are twice as likely to develop asthma in childhood, according to a study in Chest. Canadian researchers at University of British Columbia, Vancouver, reviewed seven studies made up of 12,082 children and compared exposure to at least one antibiotic to no exposure in the first year of life. The team also reviewed data from five studies made up of 27,167 children, comparing antibiotic dosing. That review showed that for each extra course of antibiotics during the first year of life a child was 1.16 times more likely to develop asthma.   

  

A word from Dr. William Dolen, president

OIG Report on Allergen Immunotherapy
The ACAAI recognizes the importance of developing standards for coverage, coding and documentation requirements for allergen immunotherapy and allergy testing, as recommended in a recent report by the Department of Health and Human Services Office of Inspector General (OIG) titled Allergen Immunotherapy for Medicare Beneficiaries.

The OIG states in the report that it considers the Joint Task Force recommendations to be “professionally recognized standards of health care.” The PDF document can be found at: http://www.oig.hhs.gov/w-new.html

The College fully supports the consensus recommendations made by the Joint Task Force on Practice Parameters, which includes the Immunotherapy and Diagnostic Testing parameters. These recommendations were not intended for use by third parties in setting standards of care. They are dynamic, and periodically updated. They do provide goals and suggestions for excellent care, and they do offer good recommendations for documentation of testing and immunotherapy. They are meant to be used at the discretion of the physician according to his or her experience; there are clinical situations in which a recommendation may not apply to an individual patient.

The ACAAI encourages its members to document a course of immunotherapy in a way that would permit third-party reviewers to recognize practice excellence. We also recognize that unduly complex documentation requirements would add to the cost of a patient visit.

The ACAAI notes the important role of professionally recognized standards of care. The College would welcome an opportunity to work with Centers for Medicare and Medicaid Services (CMS) to develop workable coverage criteria that would limit the potential for abuse of allergy diagnostic testing and immunotherapy.

-Bill


Plan to attend the ACAAI-HSACI meeting in Greece
The ACAAI and Hellenic Society of Allergy & Clinical Immunology (HSACI) are co-sponsoring a Joint Allergy Symposium, Allergy Update in Greece, Sept. 6-9, 2006, in beautiful Athens.

This international meeting brings together many of the finest researchers and clinicians to present cutting-edge lectures on the most important topics for the clinical practice of allergy and immunology.

Plan to join your colleagues in Athens, one of the most exciting cities in the world, the metropolis of wisdom, philosophy and inspiration. The modern Athens Ledra Marriott Hotel is the perfect venue for this meeting, with its spacious conference center and view of the Acropolis.
 
Drugs and Devices
Members report shortage of generic CFC-containing albuterol inhalers
The ACAAI has received increasing numbers of reports from its members of local and regional “mismatch between supply and demand” for CFC-containing generic albuterol inhalers. In most areas, pharmacists appear to be receiving what they order from the wholesalers. However, it appears that the CFC to HFA transition (scheduled to be complete by the end of 2008) has begun. We understand that there is a sufficient supply of branded CFC albuterol, HFA formulations of albuterol and levalbuterol, and other beta-2 adrenergic agents such as pirbuterol and metaproterenol.

FDA approves new primary immunodeficiency treatment
The FDA has approved an immunoglobulin product for subcutaneous use. The product, with the trade name Vivaglobin (ZLB Behring), can be given subcutaneously on a weekly basis using an infusion pump. http://www.vivaglobin.com

 

Association News
 

New Practice Parameter reveals
complexity of food allergy management

The Joint Task Force on Practice Parameters, representing the ACAAI, the American Academy of Allergy, Asthma and Immunology (AAAAI) and the Joint Council of Allergy, Asthma and Immunology (JCAAI), has published “Food Allergy: A Practice Parameter” this month in Annals of Allergy, Asthma & Immunology.

“The practice parameter on food allergy represents more than 10 years of research and investigation of literature by members of the Joint Task Force,” said Dr. Jean A. Chapman, Cape Girardeau, Mo., a chief editor. “Designed to improve patient care, the guidelines provide practicing physicians with an evidence-based, broadly accepted approach to the diagnostic evaluation and management of IgE-mediated (allergic) food reactions.”

Components of the practice parameter include an annotated algorithm that presents the major decision points for evaluation of patients suspected of having food allergy; summary statements; and sections on diagnosis and management, which are the core of the practice parameter.

“Each summary statement in the parameter is followed by supporting text. The text includes graded references that document reliability, thereby assuring a better grade of evidence,” Dr. Chapman said.

The 68-page Annals Supplement includes a detailed discussion of skin prick or puncture tests, serologic tests for specific IgE and oral food challenges. Sections discuss successful avoidance, risk factors and prevention of food allergy. Cross-reactivity of food allergy, adverse reactions to food additives, genetically modified foods, and future directions also are discussed. Recommendations for food allergy management in special settings and circumstances are included, where patients have an increased risk for unintentional food allergy exposure.


ACAAI membership at an all-time high
The ACAAI recruited 259 new members last year, bringing its total membership to an all-time high of 5,085. Of these, the average age of the 205 new physician members is 36 years.

Following is a list of the physicians who sponsored the most U.S. applications:

A. Wesley Burks, 7
Larry Hagan, 5
William Klaustermeyer, 5
Bryan Martin, 5
Charlotte Cunningham-Rundles, 4
Blanca E. Del Rio Navarro, 4
J. Andrew Grant, 4
James L. Baldwin, 3

Anita Gewurz, 3
Paul Greenberger, 3
Rhoda Kagan, 3
Jay Portnoy, 3
Sujatha Ramesh, 3
Arlene Schneider, 3
Laurianne Wild, 3

The states that provided the most new members are Texas (22), California (18), New York (17), Maryland (10), Pennsylvania (9), Missouri (9), Colorado (7) and Ohio (7).

The College invites members who are ABAI-certified to apply for Fellowship, using the membership application downloadable from the Web site.


The College honored 45 newly elected Fellows at the 2005 Convocation.
 

 
Fellows-in-Training
 

Immunology Review Corner
Welcome to the Board Review Corner, prepared by Dr. Karla R. Davis, senior representative of ACAAI’s fellows-in-training (FITs) to the Board of Regents. The Board Review Corner is your chance to test your Board preparedness.

To refer to a previous Board Review Corner, click the “Archive” link in the left column.

Immunology Review Corner: Chapter 64 (Part B) of the 6th edition of Middleton’s Allergy Principles and Practice, edited by N. Franklin Adkinson, et al. Review questions were written by Drs. Karla R. Davis, Walter Reed Medical Center; and Anne K. Ellis, McMaster University. 


Copyright © 2006 American College of Allergy, Asthma & Immunology. All rights reserved.

E-newsletter services provided by the medical editors at Ascend Media, LLC.

Do you have news, responses or opinions to share with us? Please e-mail the association office at enews@acaai.org
  
THIS E-MAIL WAS SENT FROM A “SEND-ONLY” MAILBOX. Please DO NOT REPLY to this e-mail.
ACAAI eNews is sent as a membership benefit of the American College of Allergy, Asthma & Immunology. If you would prefer not to receive future issues and want to remove your name from our mailing list, please -click here-